{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:40:28Z","timestamp":1733586028403,"version":"3.30.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,7]]},"DOI":"10.7759\/cureus.75270","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:11:41Z","timestamp":1733584301000},"source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Acyclovir Reduces the Reactivation of Herpes Simplex and Varicella Zoster Viruses After Allogeneic Stem Cell Transplantation"],"prefix":"10.7759","author":[{"given":"Sorana G","family":"Ursu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad M","family":"Alhousani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Patrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.11.249","article-title":"Risk factors and clinical outcome for herpes simplex virus reactivation in patients after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Uhlin M","year":"2015","unstructured":"Uhlin M, Stikvoort A, Sundin M, Mattsson J, Remberger M. Risk factors and clinical outcome for herpes simplex virus reactivation in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015, 21:S170.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/142.3.338","article-title":"Infection with herpes simplex virus and cell-mediated immunity after marrow transplant","volume":"142","author":"Meyers JD","year":"1980","unstructured":"Meyers JD, Flournoy N, Thomas ED. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis. 1980, 142:338-46. 10.1093\/infdis\/142.3.338","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1083-8791(00)70004-8","article-title":"Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients","volume":"6","author":"Arvin AM","year":"2000","unstructured":"Arvin AM. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2000, 6:219-30. 10.1016\/s1083-8791(00)70004-8","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.08.024","article-title":"Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: a single-center experience","volume":"134","author":"El-Haddad D","year":"2016","unstructured":"El-Haddad D, El Chaer F, Vanichanan J, et al.. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: a single-center experience. Antiviral Res. 2016, 134:58-62. 10.1016\/j.antiviral.2016.08.024","journal-title":"Antiviral Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-6-823","article-title":"Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation","volume":"100","author":"Wade JC","year":"1984","unstructured":"Wade JC, Newton B, Flournoy N, Meyers JD. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med. 1984, 100:823-8. 10.7326\/0003-4819-100-6-823","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987070.ch55","article-title":"Varicella-Zoster Virus Infections","author":"Arvin AM","year":"2003","unstructured":"Arvin AM. Varicella-Zoster Virus Infections. Thomas' Hematopoietic Cell Transplantation. Blume KG, Forman SJ, Appelbaum FR (ed): Blackwell Publishing Ltd., Oxford, United Kingdom; 2003. 732-48. 10.1002\/9780470987070.ch55"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.04.003","article-title":"Varicella zoster virus reactivation in adult survivors of hematopoietic cell transplantation: how do we best protect our patients?","volume":"24","author":"Lee CJ","year":"2018","unstructured":"Lee CJ, Savani BN, Ljungman P. Varicella zoster virus reactivation in adult survivors of hematopoietic cell transplantation: how do we best protect our patients?. Biol Blood Marrow Transplant. 2018, 24:1783-7. 10.1016\/j.bbmt.2018.04.003","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson KJ","year":"2005","unstructured":"Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant. 2005, 35:1065-9. 10.1038\/sj.bmt.1704959","journal-title":"Bone Marrow Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198107093050202","article-title":"Acyclovir prophylaxis of herpes-simplex-virus infections","volume":"305","author":"Saral R","year":"1981","unstructured":"Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med. 1981, 305:63-7. 10.1056\/NEJM198107093050202","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.10.1903","article-title":"Herpes simplex virus infection in the immunocompromised cancer patient","volume":"9","author":"Bustamante CI","year":"1991","unstructured":"Bustamante CI, Wade JC. Herpes simplex virus infection in the immunocompromised cancer patient. J Clin Oncol. 1991, 9:1903-15. 10.1200\/JCO.1991.9.10.1903","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski J","year":"2009","unstructured":"Styczynski J, Reusser P, Einsele H, et al.. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant. 2009, 43:757-70. 10.1038\/bmt.2008.386","journal-title":"Bone Marrow Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn M","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, et al.. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009, 15:1143-238. 10.1016\/j.bbmt.2009.06.019","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation-a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh M","year":"2006","unstructured":"Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation-a randomized double-blind placebo-controlled study. Blood. 2006, 107:1800-5. 10.1182\/blood-2005-09-3624","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0717-8","article-title":"Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Mascarenhas K","year":"2020","unstructured":"Mascarenhas K, Teh JB, Peng K, et al.. Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2020, 55:1662-4. 10.1038\/s41409-019-0717-8","journal-title":"Bone Marrow Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg H","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, et al.. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974, 18:295-304. 10.1097\/00007890-197410000-00001","journal-title":"Transplantation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee SJ","year":"2017","unstructured":"Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017, 129:30-7. 10.1182\/blood-2016-07-686642","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12118","article-title":"Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kawamura K","year":"2013","unstructured":"Kawamura K, Wada H, Yamasaki R, et al.. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2013, 15:457-65. 10.1111\/tid.12118","journal-title":"Transpl Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2991\/chi.d.190329.001","article-title":"Low-dose acyclovir prophylaxis for varicella zoster reactivation in autologous hematopoietic cell transplantation recipients","volume":"1","author":"Fei N","year":"2019","unstructured":"Fei N, Shah N, Cumpston A, Wen S, Ross KG, Craig M, Kanate AS. Low-dose acyclovir prophylaxis for varicella zoster reactivation in autologous hematopoietic cell transplantation recipients. Clin Hematol Int. 2019, 1:101-4. 10.2991\/chi.d.190329.001","journal-title":"Clin Hematol Int"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2012.11.354","article-title":"A single daily ultra low-dose of oral acyclovir is sufficient to prevent the occurrence of herpes zoster post hematopoietic stem cell transplantation: interim results of a prospective randomized trial","volume":"19","author":"Dennison D","year":"2013","unstructured":"Dennison D, Al Manthari IM, Al-Khabori M, et al.. A single daily ultra low-dose of oral acyclovir is sufficient to prevent the occurrence of herpes zoster post hematopoietic stem cell transplantation: interim results of a prospective randomized trial. Biol Blood Marrow Transplant. 2013, 19:S261-2.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.01.011","article-title":"Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"140","author":"Seo HM","year":"2017","unstructured":"Seo HM, Kim YS, Bang CH, Lee JH, Lee JY, Lee DG, Park YM. Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: a systematic review and meta-analysis. Antiviral Res. 2017, 140:106-15. 10.1016\/j.antiviral.2017.01.011","journal-title":"Antiviral Res"},{"key":"ref21","unstructured":"Highlights of prescribing information. Jakafi (ruxolitinib) tablets, for oral use. (2011). Accessed: November 23, 2024: https:\/\/www.jakafi.com\/jakafi-prescribing-information."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard F","year":"2020","unstructured":"Malard F, Huang XJ, Sim JP. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia. 2020, 34:1229-40. 10.1038\/s41375-020-0804-2","journal-title":"Leukemia"},{"key":"ref23","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). prevention and treatment of cancer-related infections. Version 3.2024. (2024). Accessed: November 23, 2024: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1457."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321534-low-dose-acyclovir-reduces-the-reactivation-of-herpes-simplex-and-varicella-zoster-viruses-after-allogeneic-stem-cell-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:11:44Z","timestamp":1733584304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321534-low-dose-acyclovir-reduces-the-reactivation-of-herpes-simplex-and-varicella-zoster-viruses-after-allogeneic-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.75270","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,7]]}}}